文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.

作者信息

Hsu Yueh-Han, Yu Hui-Yi, Chen Hsuan-Ju, Li Tsai-Chung, Hsu Chih-Cheng, Kao Chia-Hung

机构信息

Department of Health Services Administration, China Medical University, Taichung, Taiwan.

Division of Nephrology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.

出版信息

PLoS One. 2016 Jun 10;11(6):e0156863. doi: 10.1371/journal.pone.0156863. eCollection 2016.


DOI:10.1371/journal.pone.0156863
PMID:27284924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4902219/
Abstract

PURPOSE: The changes of the risk of peripheral arterial disease (PAD) in patients with end-stage renal disease after parathyroidectomy are scant. METHODS: We used a nationwide health insurance claims database to select all dialysis-dependent patients with end-stage renal disease aged 18 years and older for the study population in 2000 to 2006. Of the patients with end-stage renal disease, we selected 947 patients who had undergone parathyroidectomy as the parathyroidectomy group and frequency matched 3746 patients with end-stage renal disease by sex, age, years since the disease diagnosis, and the year of index date as the non-parathyroidectomy group. We used a multivariate Cox proportional hazards regression analysis with the use of a robust sandwich covariance matrix estimate, accounting for the intra-cluster dependence of hospitals or clinics, to measure the risk of peripheral arterial disease for the parathyroidectomy group compared with the non-parathyroidectomy group after adjusting for sex, age, premium-based income, urbanization, and comorbidity. RESULTS: The mean post-op follow-up periods were 5.08 and 4.52 years for the parathyroidectomy and non-parathyroidectomy groups, respectively; the incidence density rate of PAD in the PTX group was 12.26 per 1000 person-years, significantly lower than the data in the non-PTX group (24.09 per 1000 person-years, adjusted HR = 0.66, 95% CI = 0.46-0.94). CONCLUSION: Parathyroidectomy is associated with reduced risk of peripheral arterial disease in patients with end-stage renal disease complicated with severe secondary hyperparathyroidism.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5274/4902219/c3c0e110fc71/pone.0156863.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5274/4902219/92b687288952/pone.0156863.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5274/4902219/c3c0e110fc71/pone.0156863.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5274/4902219/92b687288952/pone.0156863.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5274/4902219/c3c0e110fc71/pone.0156863.g002.jpg

相似文献

[1]
The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.

PLoS One. 2016-6-10

[2]
Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.

Medicine (Baltimore). 2015-6

[3]
Risk of acute coronary syndrome after parathyroidectomy in patients with end-stage renal disease: A population-based cohort study in Taiwan.

Nephrology (Carlton). 2018-2

[4]
Impact of parathyroidectomy on survival among haemodialysis patients: A prospective cohort study.

Nephrology (Carlton). 2016-2

[5]
Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.

Int Urol Nephrol. 2015-11

[6]
Parathyroidectomy rates among United States dialysis patients: 1990-1999.

Kidney Int. 2004-1

[7]
Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis.

BMC Surg. 2016-11-29

[8]
Risk of carpal tunnel syndrome after parathyroidectomy in patients with end-stage renal disease: A population-based cohort study in Taiwan.

Medicine (Baltimore). 2020-5

[9]
Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study.

J Am Soc Nephrol. 2001-6

[10]
Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy.

J Clin Anesth. 2015-5

引用本文的文献

[1]
Hyperparathyroidism and Peripheral Arterial Disease.

Curr Vasc Pharmacol. 2024

[2]
The Relationship Between Bone Metabolism and Peripheral Artery Disease in Patients on Hemodialysis: The Potential Role of Osteocalcin.

Diabetes Metab Syndr Obes. 2023-10-26

[3]
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.

Front Endocrinol (Lausanne). 2023

[4]
Calcimimetics versus parathyroidectomy: What is preferable?

Int Urol Nephrol. 2018-7

[5]
Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Rev Endocr Metab Disord. 2017-3

[6]
Correction: The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.

PLoS One. 2016-7-5

本文引用的文献

[1]
Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism.

Biomed Res Int. 2015

[2]
Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.

Medicine (Baltimore). 2015-6

[3]
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

J Hum Hypertens. 2016-3

[4]
Prevalence of Peripheral Arterial Disease (PAD) in End Stage Renal Disease (ESRD) Patients on Hemodialysis: a study from central Nepal.

Kathmandu Univ Med J (KUMJ). 2014

[5]
Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

Kidney Int. 2015-3-18

[6]
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Clin J Am Soc Nephrol. 2015-1-7

[7]
Adynamic bone disease: from bone to vessels in chronic kidney disease.

Semin Nephrol. 2014-11

[8]
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.

Cochrane Database Syst Rev. 2014

[9]
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study.

J Hepatol. 2014-9-28

[10]
Ankle-brachial index and bone turnover in patients on dialysis.

J Am Soc Nephrol. 2015-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索